페리틴 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Ferritin Testing Market size is expected to reach USD 2.05 Billion in 2034 from USD 1.00 Billion (2025) growing at a CAGR of 8.34% during 2026-2034.

The global ferritin testing market is witnessing consistent growth due to the increasing prevalence of iron deficiency and related disorders. Ferritin tests are widely used to measure iron storage levels in the body, helping healthcare professionals diagnose conditions such as anemia, liver disease, and chronic inflammation. Growing awareness about nutritional deficiencies and routine health screening is driving the demand for ferritin testing in hospitals, diagnostic laboratories, and clinics worldwide.

One of the major drivers of this market is the rising incidence of iron deficiency anemia, particularly among women and children. Increasing healthcare awareness campaigns and government initiatives promoting early diagnosis are encouraging more individuals to undergo routine blood tests. Additionally, the growing adoption of automated diagnostic technologies in laboratories is improving testing accuracy and efficiency, further supporting the expansion of the ferritin testing market.

Looking forward, the ferritin testing market is expected to grow as healthcare systems emphasize preventive healthcare and early disease detection. Advancements in diagnostic equipment and the integration of advanced laboratory technologies will improve testing capabilities. As awareness of nutritional health and chronic disease management continues to rise, the demand for ferritin testing is projected to increase steadily over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instrument
• Reagent
• Kits

By Application

• Anemia
• Hemochromatosis
• Lead Poisoning
• Pregnancy
• Others

By End-use

• Hospitals
• Diagnostic Laboratories

COMPANIES PROFILED

• Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc, Pointe Scientific Inc, bioMrieux, Humankind Ventures Ltd, Aviva Systems Biology Corporation, Abnova Corporation, Cosmic Scientific Technologies, CTK Biotech Inc, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL FERRITIN TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instrument Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FERRITIN TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Anemia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hemochromatosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Lead Poisoning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pregnancy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FERRITIN TESTING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL FERRITIN TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL FERRITIN TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Eurolyser Diagnostica GmbH
  • 9.2.2 Cortez Diagnostics Inc
  • 9.2.3 Pointe Scientific Inc
  • 9.2.4 BioMrieux
  • 9.2.5 Humankind Ventures Ltd
  • 9.2.6 Aviva Systems Biology Corporation
  • 9.2.7 Abnova Corporation
  • 9.2.8 Cosmic Scientific Technologies
  • 9.2.9 CTK Biotech Inc
  • 9.2.10 Thermo Fisher Scientific Inc